Inhibitory effects of tart cherry (Prunus cerasus) juice on xanthine oxidoreductase activity and its hypouricemic and antioxidant effects on rats

Malaysian Journal of Nutrition

Volumn 15, Issue 1, 2009, Pages 53-64

  Haidari, F ^a   Mohammad Shahi, M ^b   Keshavarz, S A ^c   Rashidi, M R ^d  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

PRUNUS; PRUNUS CERASUS; RATTUS;

EID: 69749123892     PISSN: 1394035X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Benzie IF & Strain JJ (1996). Ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem 239(1): 70-76.
2. Blando F, Gerardi C & Nicoletti I (2004). Sour cherry (Prunus cerasus L) anthocyanins as ingredients for functional foods. J Biomed Biotechnol 2004 (5): 253-258.
3. Blau LW (1950). Cherry diet control for gout and arthritis. Tex Rep Biol Med 8(3): 309-311.
4. Min mice fed suboptimal levels of sulindac. J Agric Food Chem 54(25): 9322-9328.
5. Chaovanalikit A & Wrolstad RE (2004). Anthocyanin and polyphenolic composition of fresh and processed cherries. J Food Sci 69(1): 73-83.
6. Choi EJ (2008). Antioxidative effects of hesperetin against 7, 12-dimethylbenz (a)anthracene-induced oxidative stress in mice. Life Sci 82(21 &22): 1059-1064.
7. Fels E & Sundy JS (2008). Refractory gout: what is it and what to do about it? Curr Opin Rheumatol 20(2): 198-202.
8. Hall IH, Scoville JP, Reynolds DJ, Simlot R & Duncan P (1990). Substituted cyclic imides as potential anti-gout agents. Life Sci 46(26): 1923-1927.
9. Halvorsen BL, Carlsen MH, Phillips KM, Bøhn SK, Holte K, Jacobs DR & Blomhoff JR (2006). Content of redox-active compounds (i.e. antioxidants) in foods consumed in the United States. Am J Clin Nutr 84(1): 95-135.
10. Hou DX (2003). Potential mechanism of cancer chemoprevention by anthocyanins. Curr Mol Med 3(2): 149-159.
11. Jacob RA, Spinozzi GM, Simon VA, Kelly DS, Prior RL, Hess-Pierce B & Kader AA (2003). Consumption of cherries lowers plasma urate in healthy women. J Nutr 133(6): 1826-1829.
12. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J & Mazzali M (2003). Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41(6) 1183-1190.
13. Min mice and reduce proliferation of human colon cancer cells. Cancer Lett 194(1): 13-19.
14. Kim DO, Heo HJ, Km YJ, Yang HS & Lee CY (2005). Sweet and sour cherry phenolics and their protective effects on neuronal cells. J Agric Food Chem 53(26): 9921-9927.
15. Kinoshita T, Lepp Z, Kawai Y, Terao J & Chuman H (2006). An integrated database of flavonoids. Biofactors 26(3): 179-188.
16. Kong LD, Yang C, Ge F, Wang HD & Song GY (2004). A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J Ethnopharmacol 93(2 &3): 325-330.
17. Lee WY & Lee SM (2006). Synergistic protective effect of ischemic preconditioning and allopurinol on ischemia/reperfusion injury in rat liver. Biochem Biophys Res Commun 349(3): 1087-1093.
18. Lin CM, Chen CS, Chen CT, Liang YC & Lin JK (2002). Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem Biophys Res Commun 294(1): 167-172.
19. Maia L, Duarte RO, Freire AP, Moura JJG & Mira L (2007). NADH oxidase activity of rat and human liver xanthine oxidoreductase: potent role in superoxide production. J Biol Inorg Chem 12(6): 777-787.
20. Mo SF, Zhou F, Lv YZ, Hu QH, Zhang DM & Kong LD (2007). Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Biol Pharm Bull 30(8): 1551-1556.
21. Nguyen MTT, Awale S, Tezuka Y, Tran QL, Watanabe H & Kadota S (2004). Xnthine oxidase inhibitory activity of Vietnamese medicinal plants. Biol Pharm Bull 27(9): 1414-1421.
22. Nuki G (2006). Gout. Medicine 34(10): 417-423.
23. Potapovich AI & Kostyuk VA (2003). Comparative study of antioxidant properties and cytoprotective activity of flavonoids. Biochemistry 68(5): 514-519.
24. Prajda N & Weber G (1975). Malign transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 59(2): 245-249.
25. Rackova L, Oblozinsky M, Kostalova D, Kettmannand V & Bezakova L (2007). Free radical scavenging activity and lipoxygenase inhibition of Mahonia aquifolium extract and isoquinoline alkaloids. J Inflammation 4(1): 15-22.
26. Seeram NP, Bourquin LD & Nair MG (2001). Degradation products of cyanidin glycosides from tart cherries and their bioactivities. J Agric Food Chem 49(10): 4924-4929.
27. Seeram NP, Momin RA, Nair MG & Bourquin LD (2001). Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 8(5): 362-369.
28. Seymour E, Lewis S, Urcuyo-Llanes D & Bolling S (2008). The effect of tart cherryenriched diets on abdominal fat gene expression in rats. J Am Diet Assoc 108(9): A14 - A14.
29. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ & Klenk C (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150(1): 76-85.
30. Stinefelt B, Leonard SS, Blemings KP, Shi X & Klandorf H (2005). Free radical scavenging, DNA protection, and inhibition of lipid peroxidation mediated by uric acid. Ann Clin Lab Sci 35(1): 37-45.
31. Strazzullo P & Puig JG (2007). Uric acid and oxidative stress: relative impact on cardiovascular risk. Nutr Metab Cardiovasc Dis 17(6): 409-414.
32. Vijayalakshmi B & Chandrasekhar M (2008). Oxidative stress and their resultant products as the target molecules in clinical diagnosis of age related disease. Curr Trends Biotechnol Pharm 2(2): 239-250.
33. Wang Y, Zhu JX, Kong LD, Yang C, Cheng CHK & Zhang X (2004). Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic XDH/XO activities in oxonate-treated mice. Bas Clin Pharmacol Toxicol 94(5): 232-237.
34. Yoshioka T, Kawada K, Shimada T & Mori M (1979). Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obst Gynecol 135(3): 372-376.
35. Zhao X, Zhu JX, Mo SF, Pan Y & Kong LD (2006). Effects of cassia oil on serum and hepatic uric acid levels in oxonateinduced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol 103(3): 357-365.
36. Zhu JX, Wang Y, Kong LD, Yang C & Zhang X (2004). Effects of Biota orientalis extract and its flavonoid constituents, hesperetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol 93(1): 133-140.